Indian Pharmacopoeia Commission organizes Scientific Conclave

The Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of India, organized a Scientific Conclave & Interactive Session on Indian Pharmacopoeia 2026 today at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, in collaboration with NIPER Hyderabad, Central Drugs Standard Control Organization (CDSCO), and the IDMA Telangana Chapter. The conclave focused on the theme “Significance of Indian Pharmacopoeia Reference Standards and Impurity Standards in Ensuring Pharmaceutical Quality.”

The conference was formally inaugurated by Prof. Shailendra Saraf, Director, NIPER Hyderabad, who appreciated IPC for collaborating with academic institutions in advancing pharmaceutical quality initiatives. He highlighted that such collaborations with premier institutions, including NIPER Hyderabad and previously NIPER Ahmedabad, provide an important platform for scientific exchange and capacity building among regulators, academia, and industry stakeholders.

Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, emphasized that impurity profiling and scientifically established pharmacopoeial standards are essential components in reducing adverse effects associated with pharmaceutical impurities. He reiterated IPC’s commitment towards strengthening medicine quality systems and contributing to the vision of “Viksit Bharat” through robust pharmacopoeial standards and quality assurance mechanisms.

The conference was well attended by regulators, pharmaceutical industry professionals, academicians, clinicians, analytical scientists, and researchers from across the country, reaffirming IPC’s continued commitment towards strengthening medicine quality systems and promoting public health protection through scientifically robust pharmacopoeial standards.(UPDATED ON 15TH MAY 2026)